C1 esterase inhibitor
Showing 1 - 25 of >10,000
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium
Recruiting
- Hereditary Angioedema
- +11 more
- PHA-022121 low dose
- +3 more
-
Birmingham, Alabama
- +7 more
Dec 5, 2022
Genetic Variants in Hereditary Angioedema
Not yet recruiting
- Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
-
Barcelona, Spain
- +1 more
Apr 17, 2023
Hereditary Angioedema Trial in Moscow, Rostov-on-Don, Stavropol' (GNR-038, 50 ??/ kg, GNR-038, 100 ??/ kg, Berinert®, 20 ??/ kg)
Withdrawn
- Hereditary Angioedema
- GNR-038, 50 МЕ/ kg
- +4 more
-
Moscow, Russian Federation
- +4 more
Jan 21, 2022
Acute Ischemic Stroke, Acute Renal Injury Trial in Basel (Conestat alfa (Ruconest®), NaCl 0.9%))
Recruiting
- Acute Ischemic Stroke
- Acute Renal Injury
- Conestat alfa (Ruconest®)
- NaCl 0.9%)
-
Basel, SwitzerlandUniversity Hospital Basel, Division of Internal Medicine
Mar 16, 2022
Graft Rejection Trial in Germany, United States (Placebo, C1 Esterase Inhibitor (Human))
Completed
- Graft Rejection
- Placebo
- C1 Esterase Inhibitor (Human)
-
Los Angeles, California
- +4 more
Jun 2, 2021
Hereditary Angioedema (HAE) Trial in Miami (Recombinant human C1 esterase inhibitor, Placebo, SHP623)
Completed
- Hereditary Angioedema (HAE)
- Recombinant human C1 esterase inhibitor
- +2 more
-
Miami, FloridaClinical Pharmacology of Miami
May 13, 2021
Hereditary Angioedema Types I and II Trial in Germany, United States (C1-esterase inhibitor - single intravenous dose,
Completed
- Hereditary Angioedema Types I and II
- C1-esterase inhibitor - single intravenous dose
- +3 more
-
Atlanta, Georgia
- +7 more
Jan 29, 2021
Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))
Completed
- Hereditary Angioedema
- C1 esterase inhibitor [human] (C1INH-nf)
-
San Diego, California
- +5 more
Jun 1, 2021
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +21 more
Aug 11, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Active, not recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +35 more
Aug 23, 2022
End Stage Renal Disease, Chronic Kidney Diseases Trial in Los Angeles (Berinert, Placebo)
Active, not recruiting
- End Stage Renal Disease
- Chronic Kidney Diseases
- Berinert
- Placebo
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Jan 5, 2022
Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf), Placebo (saline))
Completed
- Hereditary Angioedema
- C1 esterase inhibitor [human] (C1INH-nf)
- Placebo (saline)
-
Scottsdale, Arizona
- +15 more
Jun 1, 2021
Hereditary Angioedema Trial in United States (CINRYZE with rHuPH20)
Completed
- Hereditary Angioedema
- CINRYZE with rHuPH20
-
Scottsdale, Arizona
- +3 more
Jun 16, 2021
Biomarker for Hereditary AngioEdema Disease
Completed
- C1 Esterase Inhibitor Deficiency
- +7 more
-
Yerevan, Armenia
- +6 more
Mar 23, 2022
Hereditary Angioedema Types I and II Trial in Worldwide (Low-volume C1-esterase inhibitor, Higher-volume C1-esterase inhibitor,
Completed
- Hereditary Angioedema Types I and II
- Low-volume C1-esterase inhibitor
- +3 more
-
Birmingham, Alabama
- +38 more
Jan 11, 2021
Coronavirus Infections Trial in Brazil, Mexico, Switzerland (Conestat alfa)
Terminated
- Coronavirus Infections
- Conestat alfa
-
São Paulo, Brazil
- +4 more
Nov 1, 2021
Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf), Placebo (saline))
Completed
- Hereditary Angioedema
- C1 esterase inhibitor [human] (C1INH-nf)
- Placebo (saline)
-
Hoover, Alabama
- +36 more
Jun 3, 2021
Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))
Completed
- Hereditary Angioedema
- C1 esterase inhibitor [human] (C1INH-nf)
-
Scottsdale, Arizona
- +29 more
May 19, 2021
Hereditary Angioedema Trial in United States (C1 inhibitor (human) [C1 INH])
Completed
- Hereditary Angioedema
- C1 inhibitor (human) [C1 INH]
-
Scottsdale, Arizona
- +10 more
Jun 17, 2021
CVI - Common Variable Immunodeficiency Trial in Centennial (C1-esterase inhibitor [recombinant] (C1-INH-R))
Completed
- CVI - Common Variable Immunodeficiency
- C1-esterase inhibitor [recombinant] (C1-INH-R)
-
Centennial, ColoradoIMMUNOe Research Centers
Feb 11, 2021
Non-ST Elevation Myocardial Infarction (NSTEMI) Trial in Switzerland (conestat alfa or )
Recruiting
- Non-ST Elevation Myocardial Infarction (NSTEMI)
- conestat alfa or placebo
-
Basel, Switzerland
- +3 more
May 27, 2021
Hereditary Angioedema (HAE) Trial in Worldwide (CINRYZE with rHuPH20)
Completed
- Hereditary Angioedema (HAE)
- CINRYZE with rHuPH20
-
Birmingham, Alabama
- +22 more
May 11, 2021
Post-Viral Fatigue Syndrome, Post-Viral Disorder (Disorder), Covid19 Trial in Centennial (Ruconest)
Recruiting
- Post-Viral Fatigue Syndrome
- +2 more
-
Centennial, ColoradoIMMUNOe Research Centers
Jan 8, 2021
Hereditary Angioedema Trial in United States (C1 esterase inhibitor [human] (C1INH-nf))
Completed
- Hereditary Angioedema
- C1 esterase inhibitor [human] (C1INH-nf)
-
Hoover, Alabama
- +47 more
May 19, 2021
Hereditary Angioedema (HAE) Trial in Worldwide (CINRYZE 500, CINRYZE 1000)
Completed
- Hereditary Angioedema (HAE)
- CINRYZE 500
- CINRYZE 1000
-
Colorado Springs, Colorado
- +7 more
May 11, 2021